Search

Search Constraints

You searched for: Author/Creator Shimada, Satoko

Search Results

2. Age‐related EBV‐associated B‐cell lymphoproliferative disorders and other EBV + lymphoproliferative diseases: New insights into immune escape and immunodeficiency through staining with anti‐PD‐L1 antibody clone SP142. Issue 8 (4th May 2020)

3. Anaplastic variant of diffuse large B‐cell lymphoma with hallmark cell appearance: Two cases highlighting a broad diversity in the diagnostics. Issue 4 (25th February 2018)

4. Diagnostic utility of programmed cell death ligand 1 (clone SP142) in mediastinal composite lymphoma: A report of two cases. Issue 2 (2nd January 2020)

5. Divergence and heterogeneity of neoplastic PD‐L1 expression: Two autopsy case reports of intravascular large B‐cell lymphoma. Issue 3 (28th January 2019)

6. Immune evasion‐related extranodal large B‐cell lymphoma: A report of six patients with neoplastic PD‐L1‐positive extranodal diffuse large B‐cell lymphoma. Issue 1 (2nd January 2019)

7. Immunohistochemical assessment of the diagnostic utility of PD‐L1: a preliminary analysis of anti‐PD‐L1 antibody (SP142) for lymphoproliferative diseases with tumour and non‐malignant Hodgkin–Reed‐Sternberg (HRS)‐like cells. Issue 7 (9th March 2018)

8. Impact of Natural Disaster Combined with Nuclear Power Plant Accidents on Local Medical Services: a Case Study of Minamisoma Municipal General Hospital after the Great East Japan Earthquake. (27th November 2014)

10. PD‐L1 (SP142) expression in neoplastic cells predicts a poor prognosis for patients with intravascular large B‐cell lymphoma treated with rituximab‐based multi‐agent chemotherapy. (5th May 2020)